The first full results of the Early Venous Reflux Ablation (EVRA) ulcer study were presented at the Charing Cross Symposium (CX; 24-27 April, London, UK). The presentation was accompanied by simultaneous publication in the New England Journal of Medicine after the session.
The randomised trial revealed that early endovenous ablation outperforms deferred treatment in healing leg ulcers. It shows early ablation of superficial venous reflux results in faster healing of venous leg ulcers and patients having much more time free from ulcers than deferred ablation does.
AZH is an innovative entrepreneurial company founded on the core principle of excellence in Vascular Medicine and Wound Care. The AZH Limb Preservation Center is the first of its kind in the Midwest to combine and integrate expertise in wound care and vascular medicine for the management of peripheral vascular disease and ulcerative critical limb ischemia into one disease focused medical practice.